Transcription initiation sites and promoter structure of the human TRAIL-R3 gene

FEBS Letters

Volumn 531, Issue 2, 2002, Pages 304-308

  Ruiz de Almodóvar, Carmen ^a   López Rivas, Abelardo ^a   Redondo, Juan Miguel ^b,c   Rodríguez, Antonio ^b,c  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Apoptosis; Decoy receptor; Doxorubicin; Promoter structure; TRAIL R3; Transcription

Indexed keywords

DOXORUBICIN; NUCLEOTIDE; PROTEIN P53; RECEPTOR; TATA BINDING PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; GENE; GENE MAPPING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR BINDING;

5' FLANKING REGION; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CLONING, MOLECULAR; DOXORUBICIN; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR SUPPRESSOR PROTEIN P53;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0037032473     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(02)03544-5     Document Type: Article

References (35)

1. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., Smith C.A. Immunity. 3:1995;673-682.
2. Pitti R.M., Marsters S.A., Ruppert S., Donahue C.J., Moore A., Ashkenazi A. J. Biol. Chem. 271:1996;12687-12690.
3. Kischkel F.C., Lawrence D.A., Chuntharapai A., Schow P., Kim K.J., Ashkenazi A. Immunity. 12:2000;611-620.
4. Sprick M.R., Weigand M.A., Rieser E., Rauch C.T., Juo P., Blenis J., Krammer P.H., Walczak H. Immunity. 12:2000;599-609.
5. Walczak H., et al. Nature Med. 5:1999;157-163.
6. Ashkenazi A., Dixit V.M. Science. 277:1998;1305-1308.
7. Pan G., Ni J., Wei Y.F., Yu G., Gentz R., Dixit V.M. Science. 277:1997;815-818.
8. Walczak H., Degli-Esposti M.A., Johnson R.S., Smolak PlJ., Waugh J.Y., Boiani N., Timour M.S., Gerhart M.J., Schooley K.A., Smith C.A., Goodwin R.G., Rauch C.T. EMBO J. 16:1997;5386-5397.
9. Sheridan J.P., Marsters S.A., Pitti R.M., Gurney A., Skubatch M., Baldwin D., Ramakrishnan L., Gray C.L., Baker K., Wood W.I., Goddard A.D., Godowski P., Ashkenazi A. Science. 277:1997;818-821.
10. MacFarlane M., Ahmad M., Srinivasula S.M., Fernandes-Alnemri T., Cohen G.M., Alnemri E.S. J. Biol. Chem. 272:1997;25417-25420.
11. Degli-Esposti M.A., Smolak P.J., Walczak H., Waugh J., Huang C.-P., DuBose R.F., Goodwin R.G., Smith C.A. J. Exp. Med. 187:1997;1165-1170.
12. Pan G., Ni J., Wei Y.F., Yu G., Gentz R., Dixit V.M. FEBS Lett. 424:1998;41-45.
13. Golstein P. Curr. Biol. 7:1997;750-753.
14. Griffith T.S., Chin W.A., Jackson G.C., Lynch D.H., Kubin M.Z. J. Immunol. 161:1998;2833-2840.
15. Leverkus M., Neumann M., Mengling T., Rauch C.T., Brocker E.B., Krammer P.H., Walczak H. Cancer Res. 60:2000;553-559.
16. Zhang X.D., Nguyent T., Thomas W.D., Sanders J.E., Hersey P. FEBS Lett. 482:2000;193-199.
17. Yoshida T., Ayaka M., Tani N., Sakai T. FEBS Lett. 507:2001;381-385.
18. van Noesel M.M., van Bezouw S., Salomons G.S., Voute P.A., Pieters R., Baylin S.B., Herman J.G., Versteeg R. Cancer Res. 62:2002;2157-2161.
19. Guan B., Yue P., Lotan R., Sun S.Y. Oncogene. 20:2002;3121-3129.
20. Sheikh M.S., Burns T.F., Huang Y., Wu G.S., Amundson S., Brooks K.S., Fornace A.J. Jr., El-Deiry W.S. Cancer Res. 58:1998;1593-1598.
21. Sheikh M.S., Huang Y., Fernandez-Salas E.A., El Deiry W.S., Friess H., Amundson S., Yin J., Meltzer S.J., Holbrook N.J., Fornace A.J. Jr. Oncogene. 18:1999;4153-4159.
22. Bernard D., Quatannens B., Vandenbunder B., Abbadie C. J. Biol. Chem. 276:2001;27322-27328.
23. The International Human Genome Sequencing Consortium (2001) Nature 409, 860-921.
24. Ruiz-Ruiz M.C., Lopez-Rivas A. Cell Death Differ. 6:1999;271-280.
25. Nordeen S.K. BioTechniques. 6:1988;454-456.
26. Lorenzo E., Ruiz-Ruiz C., Quesada A.J., Hernández G., Rodríguez A., López-Rivas A., Redondo J.M. J. Biol. Chem. 277:2002;10883-10892.
27. Morgestern J., Land H. Methods Mol. Biol. 7:1991;181-206.
28. Keane M.M., Ettenberg S.A., Nau M.M., Russell E.K., Lipkowitz S. Cancer Res. 59:1999;734-741.
29. Ruiz-Ruiz C., Lopez-Rivas A. Biochem. J. 365:2002;825-832.
30. Marsters S.A., Sheridan J.P., Pitti R.M., Huang A., Skubatch M., Baldwin D., Yuan J., Gurney A., Goddard A.D., Godowski P., Ahskenazi A. Curr. Biol. 7:1997;1003-1006.
31. Wu G.S., Burns T.F., McDonald E.R., Jiang W., Meng R., Krantz I.D., Kao S., Wu G., El Deiry W.S. Nature Genet. 17:1997;141-143.
32. Muller M., et al. J. Exp. Med. 188:1998;2033-2045.
33. Takimoto R., El-Deiry W.S. Oncogene. 19:2000;1735-1743.
34. Das K.C., White C.W. J. Biol. Chem. 272:1997;14914-14920.
35. Adderley S.R., Fitzgerald D.J. J. Biol. Chem. 274:1999;5038-5046.